Show items per page
Elements: 52
Page 1 on 3
 TitleAuthors / EditorsDate
add to browser selection
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure Marcelin, Anne-Geneviève; Delaugerre, Constance; Beaudoux, Céline; Descamps, Diane; ... Flandre, Philippe 2013
add to browser selection
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study Assoumou, Lambert; Descamps, Diane; Yerly Ferrillo, Sabine; Dos Santos, Georges; ... Masquelier, Bernard 2013
add to browser selection
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients Calmy, Alexandra; Bel, Michael; Nguyen, A; Combescure, Christophe; ... Villard, Jean 2012
add to browser selection
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients Scherrer, Alexandra U; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2012
add to browser selection
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; Yerly Ferrillo, Sabine; ... Günthard, Huldrych F 2011
add to browser selection
Management of hepatitis C virus (HCV) infection in drug substitution programs Witteck, Andrea; Schmid, Patrick; Hensel-Koch, Katharina; Thurnheer, Maria C; ... Moradpour, D 2011
add to browser selection
The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients Fattovich, Giovanna; Covolo, Loredana; Pasino, Michela; Perini, Eleonora; ... Donato, Francesco 2011
add to browser selection
Hepatitis D virus: an update Pascarella Rochat, Stéphanie; Negro, Francesco 2011
add to browser selection
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. Bochud, Pierre-Yves; Bibert, Stéphanie; Negro, Francesco; Haagmans, B; ... Lagging, M 2011
add to browser selection
Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study Osih, Regina B.; Taffe, Patrick; Rickenbach, Martin; Gayet-Ageron, Angèle; ... Cavassini, Matthias 2010
add to browser selection
Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C Sgier, C.; Mullhaupt, B.; Gerlach, T.; Moradpour, D.; ... Dufour, Jean-François 2010
add to browser selection
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study Gonvers, Jean-Jacques; Heim, Markus H.; Cavassini, Matthias; Mullhaupt, Beat; ... Oneta, Carl 2010
add to browser selection
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia Simioni, Samanta; Cavassini, Matthias; Annoni, Gian-Maria; Rimbault Abraham, Aline; ... Du Pasquier, Renaud A. 2010
add to browser selection
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy Rohrbach, Janine; Robinson, Nicola; Harcourt, Gillian; Hammond, Emma; ... Rauch, Andri 2010
add to browser selection
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals Elzi, Luigia; Kaufmann, Gilbert; Weber, Rainer; Fux, C. A.; ... Battegay, Manuel 2009
add to browser selection
Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir Ananworanich, Jintanat; Gayet-Ageron, Angèle; Ruxrungtham, Kiat; Chetchotisakd, Ploenchan; ... Hirschel, Bernard 2008
add to browser selection
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial El-Sadr, W. M.; Grund, B.; Neuhaus, J.; Babiker, A.; ... Neaton, J. D. 2008
add to browser selection
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era Boffi El Amari, Emmanuelle; Toutous-Trellu, Laurence; Gayet-Ageron, Angèle; Baumann, Michele; ... Hirschel, Bernard 2008
add to browser selection
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy Pugnale, Paolo; Herrmann, Eva; Neumann, Avidan U.; Pawlotsky, Jean-Michel; ... Negro, Francesco 2008
add to browser selection
Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy Ananworanich, Jintanat; Nuesch, Reto; Côté, Hélène C. F.; Kerr, Stephen J.; ... Hirschel, Bernard 2008
<< previous | 1 | 2 | 3 |